title: Adverse outcome of early recurrent ischemic stroke secondary to atrial fibrillation after repeated systemic thrombolysis.
abstract: Background. Recurrent ischemic stroke is associated with adverse neurological outcome in patients with atrial fibrillation. There is very scarce information regarding the neurological outcome of atrial fibrillation patients undergoing repeated systemic thrombolysis after early recurrent ischemic stroke. Clinical Case and Discussion. We describe a case of a 76-year-old woman with known paroxysmal atrial fibrillation who was admitted because of an acute right middle cerebral artery ischemic stroke and who underwent repeated systemic thrombolysis within 110 hours. The patient underwent systemic thrombolysis after the first ischemic stroke with almost complete neurological recovery. On the fourth day after treatment, an acute left middle cerebral artery ischemic stroke was diagnosed and she was treated with full-dose intravenous recombinant tissue plasminogen activator. A hemorrhagic transformation of the left middle cerebral artery infarction was noted on follow-up cranial computed tomographic scans. The patient did not recover from the second cerebrovascular event and died 25 days after admission. Conclusion. To the best of our knowledge, this is the second case reporting the adverse neurological outcome of a patient with diagnosis of atrial fibrillation undergoing repeated systemic thrombolysis after early recurrent ischemic stroke. Our report represents a contribution to the scarce available evidence suggesting that repeated systemic thrombolysis for recurrent ischemic stroke should be avoided.
authors: Vascular Research Institute, INECO Foundation, Pacheco de Melo 1860, Ciudad de Buenos Aires (C1126AAB), Buenos Aires, Argentina.
authors: Luciano A
authors: LA
authors: Sposato
authors: Valeria
authors: V
authors: Salutto
authors: Diego E
authors: DE
authors: Beratti
authors: Paula
authors: P
authors: Monti
authors: Patricia M
authors: PM
authors: Riccio
authors: Claudio
authors: C
authors: Mazia
references: Circulation. 2002 Apr 9;105(14):1679-85
references: 11940547
references: Fundam Appl Toxicol. 1996 Apr;30(2):243-54
references: 8812272
references: Thromb Haemost. 1990 Oct 22;64(2):276-80
references: 2125377
references: N Engl J Med. 1995 Dec 14;333(24):1581-7
references: 7477192
references: Int J Stroke. 2009 Aug;4(4):237-8
references: 19689747
references: Stroke. 2008 Dec;39(12):3316-22
references: 18927461
references: Stroke. 2004 Jul;35(7):1671-6
references: 15166391
references: Stroke. 2005 Nov;36(11):e162-4
references: 16210551
references: Stroke. 2010 Aug;41(8):1829-32
references: 20616322
references: Stroke. 2001 Feb;32(2):438-41
references: 11157179
references: J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1093-9
references: 18223014
references: Stroke. 2009 Aug;40(8):2945-8
references: 19478221
references: Fundam Appl Toxicol. 1992 Nov;19(4):555-62
references: 1426714
references: Stroke. 2010 Sep;41(9):1990-5
references: 20705933
references: Blood Coagul Fibrinolysis. 2010 Sep;21(6):605-7
references: 20644467
references: Stroke. 2006 May;37(5):1151-2; author reply 1152-3
references: 16556876
references: Stroke. 2002 Mar;33(3):831-6
references: 11872911
references: Lancet. 1998 Oct 17;352(9136):1245-51
references: 9788453
references: Stroke. 1999 May;30(5):1142-3
references: 10229756
references: J Clin Neurol. 2008 Mar;4(1):29-32
references: 19513321
references: Postgrad Med J. 2008 Jul;84(993):361-7
references: 18716015
references: N Engl J Med. 2008 Sep 25;359(13):1317-29
references: 18815396